Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Postoperative recurrence; Oligometastases; Progression-free survival; Local therapy;
مقالات ISI سرطان غیر سلول کوچک ریه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA); Non-small cell lung cancer not otherwise specified (NSCLC-NOS); Epidermal growth factor receptor (EGFR) testing; Histological subtyping of non-small cell lu
Keywords: سرطان غیر سلول کوچک ریه; Erlotinib; Bevacizumab; Non-squamous; Non-small cell lung cancer; First-line; Combination therapy;
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Celecoxib; Chemotherapy; Survival; Plasma VEGF;
Keywords: سرطان غیر سلول کوچک ریه; Pemetrexed; Cost effectiveness; Paclitaxel; Bevacizumab; Non-small cell lung cancer; Survival outcomes;
Keywords: سرطان غیر سلول کوچک ریه; Radiation-induced pneumopathy; Radiation pneumonitis; Interstitial lung changes; Radiotherapy; Non-small cell lung cancer;
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Technology utilization; IMRT; Radiation technique; Comparative effectiveness;
Keywords: سرطان غیر سلول کوچک ریه; Stereotactic body radiotherapy; Non-small cell lung cancer; Dose-response modeling; Linear-quadratic formalism; Biologically effective dose;
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Dendritic cell vaccine; Wilms' tumour-1; Overall survival;
Keywords: سرطان غیر سلول کوچک ریه; Meta-analysis; non-small cell lung cancer; overall response rate; overall survival; progression-free survival; randomised controlled trials; vandetanib;
Keywords: سرطان غیر سلول کوچک ریه; Biological equivalent dose; dose-response study; non-small cell lung cancer; predictive modelling; radiation therapy;
Keywords: سرطان غیر سلول کوچک ریه; acneiform rash; cutaneous side effects; epidermal growth factor receptor inhibitor; erlotinib; Japanese patients; non-small cell lung cancer; prevention; skin toxicities; ADL; activities of daily living; AEs; adverse events; BSA; body surface area; CI; co
Keywords: سرطان غیر سلول کوچک ریه; Lung cancer; Non-small cell lung cancer; Thermal Ablation; Radiofrequency ablation; Microwave Ablation; Cryoablation; Electrochemotherapy; Electroporation;
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Advanced disease; New systemic therapies;
Keywords: سرطان غیر سلول کوچک ریه; NSCLC; Non-small cell lung cancer; Sentinel node biopsy; Systematic review; Meta-analysis; Detection rate; False negative rate;
Keywords: سرطان غیر سلول کوچک ریه; NSCLC; non-small cell lung cancer; GSEA; gene set enrichment analysis; IG; information gain; WWTR1; WW domain containing transcription regulator 1; SEMA5A; sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and s
Keywords: سرطان غیر سلول کوچک ریه; AML; acute myeloid leukemia; CAM-DR; cell adhesion-mediated drug resistance; CCP; charge-conversion polymer; CLL; chronic lymphocytic leukemia; CNS; central nervous system; CSC; cancer stem cell; EGFR; epidermal growth factor receptor; EPR; enhanced perme
Keywords: سرطان غیر سلول کوچک ریه; ACTRIIB; activin receptor type-2B; APC; adenomatosis polyposis coli; APPR; acute phase protein response; ARC; arcuate nucleus; ATP; adenosine-5â²-triphosphate; C-26; colon-26 adenocarcinoma mouse model; CHO; Chinese hamster ovary; COPD; chronic obstructi
Keywords: سرطان غیر سلول کوچک ریه; EGFR mutation; KRAS mutation; ROS1; Non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; RET; Sorafenib; Non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; Electrochemical impedance spectrometry; Cytosensor; Aptamers; Non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; APC; RAR-β; Methylation; Prognosis
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Crizotinib; ALK rearrangement
Keywords: سرطان غیر سلول کوچک ریه; Lung neoplasms; Non-small cell lung cancer; Physical activity; Function; Physiotherapy; Health-related quality of life
Keywords: سرطان غیر سلول کوچک ریه; Medication-taking; Grounded theory; Non-small cell lung cancer; Erlotinib; Epidermal growth factor receptor
Keywords: سرطان غیر سلول کوچک ریه; bronchoscopy; endoscopy; mediastinoscopy; mediastinum; staging; TBNA; CUS; combined endoscopic and endobronchial ultrasound; EBUS; endobronchial ultrasound; EUS; endoscopic ultrasound; LR; likelihood ratio; NSCLC; non-small cell lung cancer; ROSE; rapid o
Expression and function of lncRNA MALAT-1 in the embryonic development of zebrafish
Keywords: سرطان غیر سلول کوچک ریه; AS; alternative splicing; B-MYB; Myb-related protein B; Egr1; early growth response 1; hpf; hour post-fertilization; lncRNA; long non-coding RNA; MALAT-1; metastasis-associated lung adenocarcinoma transcript 1; mascRNA; MALAT-1-associated small cytoplasmi
Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Long non-coding RNA SNHG16; miR-146a; MUC5AC; Proliferation; Migration; Invasion;
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: سرطان غیر سلول کوچک ریه; ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
The function and clinical significance of eIF3 in cancer
Keywords: سرطان غیر سلول کوچک ریه; eIFs; eukaryotic translation initiation factors; eIF3; eukaryotic translation initiation factor 3; IRES; internal ribosome entry site; PABP; polyA binding protein; CKIs; cyclin-dependent kinase inhibitors; NER; nucleotide excision repair; GC; gastric carc
Thoracoscopic lobectomy with mediastinal lymph node dissection as a standard surgery for T1-2N0M0 non-small cell lung cancer (>300 surgeries experience)
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Thoracoscopic lobectomy; VATS; Mediastinal lymph node dissection;
Benefit of crizotinib in a lung cancer patient with discordant ALK testing results
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Immunohistochemistry; Fluorescence In-situ Hybridization; Targeted Therapy;
Inhibitory effect of 11-carbonyl-beta-boswellic acid on non-small cell lung cancer H446 cells
Keywords: سرطان غیر سلول کوچک ریه; 11-Carbonyl-β-boswellic acid; Non-small cell lung cancer; H466; Apoptosis;
Case Report: Osimertinib achieved remarkable and sustained disease control in an advanced non-small-cell lung cancer harboring EGFR H773L/V774M mutation complex
Keywords: سرطان غیر سلول کوچک ریه; EGFR; Complex mutations; Tyrosine kinase inhibitors; Non-small cell lung cancer; Osimertinib;
Long noncoding RNAs act as regulators of autophagy in cancer
Keywords: سرطان غیر سلول کوچک ریه; lncRNA; long noncoding RNA; miRNA; microRNA; EMT; epithelial-mesenchymal transition; Atg; autophagy-related gene; HOTAIR; HOX antisense intergenic RNA; HCC; hepatocellular carcinoma; HULC; highly upregulated liver cancer; MALAT1; metastasis-associated lun
The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA)
Keywords: سرطان غیر سلول کوچک ریه; Staging non-small cell lung cancer; Unforeseen N2; Stage IIIA NSCLC; ASA; American Society of Anaesthesiologists; cN; clinical nodal stage; cT; clinical tumor stage; cTNM; clinical stage; DLCO; diffuse capacity of the lung for carbon monoxide; DLSA; Dutch
Time and dose-related changes in lung perfusion after definitive radiotherapy for NSCLC
Keywords: سرطان غیر سلول کوچک ریه; Radiation pneumonitis; SPECT/CT; Functional imaging; Lung perfusion; Non-small cell lung cancer; IMRT;
Upregulation of LncRNA FEZF-AS1 is associated with advanced clinical stages and family history of cancer in patients with NSCLC
Keywords: سرطان غیر سلول کوچک ریه; Antisense RNA; FEZF-AS1; Non-small cell lung cancer; Clinical stages; FEZF1;
Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; Tyrosine kinase inhibitors; Osimertinib;
Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis
Keywords: سرطان غیر سلول کوچک ریه; Cell-free DNA; Non-small cell lung cancer; Tuberculosis; Biomarker;
Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on bioinformatics analyses
Keywords: سرطان غیر سلول کوچک ریه; NSCLC; non-small cell lung cancer; ALK; anaplastic lymphoma kinase; GEO; gene expression omnibus; DEGs; differentially expressed genes; DAVID; database for annotation, visualization and integrated discovery; GO; gene ontology; KEGG; kyoto encyclopedia of
Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the 18F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; GLUT-1; SGLT-1; SGLT-2; Mediastinal lymph node; False negative; True positive; 18F-FDG PET/CT; Non-small cell lung cancer;
Comparison of up-front radiotherapy and TKI with TKI alone for NSCLC with brain metastases and EGFR mutation: A meta-analysis
Keywords: سرطان غیر سلول کوچک ریه; Non-small cell lung cancer; EGFR mutation; Brain metastases; Radiotherapy; Tyrosine kinase inhibitor;
ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease
Keywords: سرطان غیر سلول کوچک ریه; ILD; interstitial lung disease; NSCLC; non-small cell lung cancer; AE; acute exacerbation; IPF; idiopathic pulmonary fibrosis; %FVC; percent predicted forced vital capacity; %DLCO; percent predicted diffusion capacity of lung for carbon monoxide; TKI; tyr
Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea
Keywords: سرطان غیر سلول کوچک ریه; Afatinib; Epidermal growth factor receptor; Compassionate use pragram; Non-small cell lung cancer;
Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants
Keywords: سرطان غیر سلول کوچک ریه; ALK translocation; Non-small cell lung cancer; Crizotinib; Next-generation sequencing; Variants;
miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer
Keywords: سرطان غیر سلول کوچک ریه; miR-486-5p; Oncogene; Non-small cell lung cancer; PTEN; Therapy;
A novel combined score of biomarkers in sputum may be an indicator for lung cancer: A pilot study
Keywords: سرطان غیر سلول کوچک ریه; Inflammation; Biomarkers; Screening; Angiogenesis; ANOVA; Analysis of Variance; ATS; American Thoracic Society; BMI; Body Mass Index; CI; Confidence Interval; COPD; Chronic Obstructive Pulmonary Disease; ECOG; Eastern Cooperative Oncology Group; ELISA; En
Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions
Keywords: سرطان غیر سلول کوچک ریه; NSCLC; non-small cell lung cancer; HLA; human leukocyte antigens; LDCT; low-dose computed tomography; MHC; major histocompatibility complex; ATCC; American Type Culture Collection; RPMI; Roswell Park Memorial Park; SDS-PAGE; standard denaturing polyacryla
A novel oncogene URG4/URGCP and its role in cancer
Keywords: سرطان غیر سلول کوچک ریه; HCC; hepatocellular carcinoma; HBxAg; hepatitis B x antigen; URG4/URGCP; up-regulated gene 4/Upregulator of cell proliferation; RACE; Rapid Amplification of 5 'and 3' cDNA Ends; PCNA; Proliferating Cell Nuclear Antigen; GES-1; immortalized gastric epi